Shikimate Kinase, a Protein Target for Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|5|592-604

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.5, 2014-02, pp. : 592-604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Shikimate Kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: Kinetics and Structural Dynamics of a Potential Molecular Target for Drug Development

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1299-1310

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Calmodulin Kinase: A Potential Target for Drug Design

By  

Current Medicinal Chemistry, Vol. 18, Iss. 24, 2011-08 ,pp. : 3707-3713

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterial Shikimate Pathway Enzymes as Targets for Drug Design

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-01 ,pp. : 423-435

Bentham Science Publishers

Access to resources Recommend Favorite

Abelson Tyrosine-Protein Kinase 1 as Principal Target for Drug Discovery Against Leukemias. Role of the Current Computer-Aided Drug Design Methodologies

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 24, 2012-12 ,pp. : 2745-2762

Bentham Science Publishers

Access to resources Recommend Favorite

Shikimate Kinase: A Potential Target for Development of Novel Antitubercular Agents

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 459-468

Bentham Science Publishers

Access to resources Recommend Favorite